Blood Test Identifies Key Alzheimer’s Marker Summary: Researchers have devised a new blood test that can detect if amyloid had begun to accumulate in the brain. The test help physicians diagnose Alzheimer’s disease in a cheaper, less invasive way than currently available. The researchers will present their findings at the Alzheimer’s Association International Conference in
Category: Alzheimer’s Disease
Drugs Pimavanserin for Agitation and Aggression in Alzheimer’s Disease (multiple sites) Crenezumab for Prodromal to Mild Alzheimer’s Disease (multiple sites) Brain Imaging Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3) (multiple sites) Caregiving Tele-Savvy Education Program for Dementia Caregivers (Atlanta, GA) Caring for the Caregiver Technology-Based Program (Miami, FL) Exercise Exercise in Adults with Mild Memory Problems (EXERT) (multiple sites)
Summary: A new study published in brain reveals that just one night of sleep disruption causes an increase in amyloid beta in the brains of healthy, middle aged people. A full week of sleep disturbances leads to a build up of Tau, another protein associated with Alzheimer’s and other neurodegenerative diseases. The study sheds light
Do most people get Alzheimer’s disease and if so should they not learn anything new? Only 25% of seniors get Alzheimer’s disease, 3x more with women, who are over stressed, hormonal imbalance, on meat diet with processed foods/toxic food, do not exercise, on sugary and toxic diet and has genetic predisposition (15% contribution). Alzheimer’s/Dementia is
A Multidomain Two-Year Randomized Controlled Trial to Prevent Cognitive Impairment- the FINGER study Special Report courtesy of the Alzheimer’s Research and Prevention Foundation, which is one of the funding sources for the FINGER study. Background: Observational studies have identified multiple modifiable risk factors associated with increased risk of late-life cognitive impairment and Alzheimer’s disease (AD).